Clinical rheumatology
-
Clinical rheumatology · Dec 2019
Randomized Controlled TrialPlatelet-rich plasma in treatment of patients with idiopathic carpal tunnel syndrome.
Carpal tunnel syndrome (CTS) is the most common entrapment neuropathy in the upper extremity. Treatments for CTS alternate from conservative strategies to surgical decompression of median nerve. Few studies have applied platelet-rich plasma (PRP) for treating idiopathic CTS, with acceptable success rates. Further studies are needed to reach concrete conclusion. ⋯ Platelet-rich plasma could be effective treatment of mild to moderate idiopathic CTS and superior to corticosteroid in improving pain, function, and distal sensory latency of median nerve.